Position in GRFS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$339
New position
Shares Held
48
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#158
of 164 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First Command Advisory Services, Inc. holds $9,332,951 across 16 Drug Manufacturers - General names. GRFS ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,195 | $2,632,749 | |
| 2 | JNJ |
Johnson & Johnson
|
9,995 | $2,538,430 | |
| 3 | ABBV |
AbbVie Inc.
|
4,617 | $1,161,821 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,568 | $843,988 | |
| 5 | AMGN |
Amgen Inc
|
2,303 | $833,962 | |
| 6 | NVS |
Novartis AG
|
4,108 | $643,805 | |
| 7 | PFE |
Pfizer Inc
|
8,442 | $203,283 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,729 | $157,244 |
All Filings in GRFS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $339 | 48 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||